放射線毒性治療市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、適応症別、放射線タイプ別、エンドユーザー別、地域別、競合別、2020-2030F

放射線毒性治療の世界市場規模は2024年に24億8,000万米ドルとなり、予測期間では2030年までCAGR 5.40%で着実な成長が予測されています。

放射線毒性治療の世界市場は、がんの罹患率の増加やがん治療における放射線治療の利用拡大により、近年著しい成長と進化を遂げています。放射線療法は腫瘍学において重要な手段であるが、放射線毒性につながる可能性があり、しばしば専門的な治療や管理戦略が必要となります。この市場には、放射線療法の副作用を緩和・治療することを目的とした幅広い製品とサービスが含まれており、放射線療法は現代のがん治療において不可欠な要素となっています。

この市場の成長促進要因は、世界のがん罹患率の上昇です。がんの罹患率が世界的に上昇を続ける中、放射線療法を受ける患者数も大幅に増加しています。しかし、放射線療法に副作用がないわけではなく、皮膚反応、胃腸障害、臓器障害などの放射線毒性が一般的な懸念事項となっています。このため、医薬品、医療機器、支持療法サービスなどの放射線毒性治療オプションの需要に拍車がかかっています。医薬品は放射線毒性治療市場の重要なセグメントを形成しており、放射線毒性の症状を管理・緩和するために開発された医薬品や薬剤があります。これらの医薬品には、抗炎症薬、成長因子、放射線防護薬などが含まれます。さらに、標的治療薬や免疫調節薬の進歩は、放射線治療の効果を向上させるとともに、関連する毒性を軽減させることが期待されています。

主な市場促進要因

がん罹患率の増加

主な市場課題

限られた認識と教育

主要市場動向

放射線防護剤と支持療法

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 放射線毒性治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（コロニー刺激因子、ヨウ化カリウム、プルシアンブルージエチレントリアミン五酢酸、その他）
  • 適応症別（急性放射線症候群、慢性放射線症候群）
  • 放射線の種類別（電離放射線、非電離放射線）
  • エンドユーザー別（病院・診療所、外来診療センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の放射線毒性治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の放射線毒性治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の放射線毒性治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の放射線毒性治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの放射線毒性治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の放射線毒性治療市場：SWOT分析

第14章 競合情勢

• Amgen Inc.
• Jubilant Pharma Limited
• Tanner Pharma Group
• Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
• Recipharm AB
• Mission Pharmacal Company
• Partner Therapeutics, Inc.
• Novartis AG
• Viatris Inc.
• Coherus Biosciences Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Radiation Toxicity Treatment Market was valued at USD 2.48 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.40% through 2030. The Global Radiation Toxicity Treatment Market has witnessed significant growth and evolution in recent years, driven by the increasing incidence of cancer and the expanding use of radiation therapy in cancer treatment. Radiation therapy, while a crucial tool in oncology, can lead to radiation toxicity, which often necessitates specialized treatments and management strategies. This market encompasses a wide range of products and services aimed at mitigating and treating the adverse effects of radiation therapy, making it an essential component of modern cancer care.

The primary drivers of this market's growth is the rising global cancer burden. As cancer incidence continues to rise worldwide, the number of patients undergoing radiation therapy has increased substantially. However, radiation therapy is not without its side effects, and radiation toxicity, including skin reactions, gastrointestinal issues, and organ damage, is a common concern. This has spurred the demand for radiation toxicity treatment options, including pharmaceuticals, medical devices, and supportive care services. Pharmaceuticals form a crucial segment of the radiation toxicity treatment market, with drugs and medications developed to manage and alleviate the symptoms of radiation toxicity. These pharmaceuticals include anti-inflammatory agents, growth factors, and radioprotective drugs. Additionally, advancements in targeted therapies and immunomodulators hold promise for improving the effectiveness of radiation therapy while reducing associated toxicities.

Key Market Drivers

Increasing Cancer Prevalence

The escalating global incidence of cancer significantly propels the growth of the Radiation Toxicity Treatment Market. This surge in cancer cases leads to increased utilization of radiation therapy, consequently amplifying the demand for treatments addressing radiation-induced toxicities. Recent studies indicate a substantial rise in cancer cases worldwide. For instance, projections suggest in 2022, approximately 20 million new cancer cases were reported globally, resulting in nearly 10 million deaths. Demographic projections suggest that the annual incidence of cancer will rise to 35 million by 2050, representing a 77% increase from 2022 figures. This surge is particularly pronounced in low- and middle-income countries, where healthcare infrastructure may struggle to accommodate the growing burden.

Key Market Challenges

Limited Awareness and Education

One of the primary challenges is the lack of awareness among patients undergoing radiation therapy. For many individuals diagnosed with cancer, the focus understandably shifts to the cancer itself and its treatment. Patients may not be fully informed about the potential side effects of radiation therapy, which can include skin irritation, fatigue, gastrointestinal issues, and damage to healthy tissues. Consequently, they may not actively seek information about radiation toxicity treatment options that could mitigate these adverse effects.

This lack of awareness can lead to suboptimal patient experiences, as individuals may not be proactive in discussing radiation toxicity concerns with their healthcare providers. As a result, they may endure unnecessary discomfort and a reduced quality of life during their treatment journey.

Key Market Trends

Radioprotective Agents and Supportive Care

Radioprotective agents and supportive care have emerged as powerful drivers boosting the Global Radiation Toxicity Treatment Market. These components of radiation toxicity management are gaining increasing attention and significance in the field of cancer care.

Radioprotective agents are pharmaceuticals and treatments developed to shield healthy tissues from the damaging effects of radiation therapy while simultaneously enhancing the tumor's sensitivity to radiation. These agents are designed to minimize radiation-induced toxicities, making radiation therapy safer and more tolerable for patients. The development of radioprotective drugs represents a major breakthrough, as it allows oncologists to optimize radiation treatment protocols without compromising their efficacy. As a result, patients can receive higher doses of radiation to target cancer cells more effectively while experiencing fewer side effects, driving the demand for such agents and boosting the radiation toxicity treatment market.

Key Market Players

• Amgen Inc.
• Jubilant Pharma Limited
• Tanner Pharma Group
• Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
• Recipharm AB
• Mission Pharmacal Company
• Partner Therapeutics, Inc.
• Novartis AG
• Viatris Inc.
• Coherus Biosciences Inc

Report Scope:

In this report, the Global Radiation Toxicity Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiation Toxicity Treatment Market, By Product:

• Colony Stimulating Factors
• Potassium Iodide
• Prussian Blue Diethylenetriamine Pentaacetic Acid
• Others

Radiation Toxicity Treatment Market, By Indication:

• Acute Radiation Syndrome
• Chronic Radiation Syndrome

Radiation Toxicity Treatment Market, By End-user:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Radiation Toxicity Treatment Market, By Radiation Type:

• Ionizing Radiation
• Non-ionizing Radiation

Radiation Toxicity Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Radiation Toxicity Treatment Market.

Available Customizations:

Global Radiation Toxicity Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Radiation Toxicity Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Colony Stimulating Factors, Potassium Iodide, Prussian Blue Diethylenetriamine Pentaacetic Acid, Others)
  • 5.2.2. By Indication (Acute Radiation Syndrome, Chronic Radiation Syndrome)
  • 5.2.3. By Radiation Type (Ionizing Radiation, Non-ionizing Radiation)
  • 5.2.4. By End-user (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Radiation Toxicity Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Radiation Type
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Radiation Toxicity Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Radiation Type
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Radiation Toxicity Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Radiation Type
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Radiation Toxicity Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Radiation Type
      • 6.3.3.2.4. By End User

7. Europe Radiation Toxicity Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Radiation Type
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Radiation Toxicity Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Radiation Type
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Radiation Toxicity Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Radiation Type
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Radiation Toxicity Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Radiation Type
      • 7.3.3.2.4. By End User
  • 7.3.4. France Radiation Toxicity Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Radiation Type
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Radiation Toxicity Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Radiation Type
      • 7.3.5.2.4. By End User

8. Asia-Pacific Radiation Toxicity Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Radiation Type
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Radiation Toxicity Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Radiation Type
      • 8.3.1.2.4. By End User
  • 8.3.2. India Radiation Toxicity Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Radiation Type
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Radiation Toxicity Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Radiation Type
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Radiation Toxicity Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Radiation Type
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Radiation Toxicity Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Radiation Type
      • 8.3.5.2.4. By End User

9. South America Radiation Toxicity Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Radiation Type
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Radiation Toxicity Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Radiation Type
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Radiation Toxicity Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Radiation Type
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Radiation Toxicity Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Radiation Type
      • 9.3.3.2.4. By End User

10. Middle East and Africa Radiation Toxicity Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Radiation Type
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Radiation Toxicity Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Radiation Type
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Radiation Toxicity Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Radiation Type
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Radiation Toxicity Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Radiation Type
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Radiation Toxicity Treatment Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Amgen Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Jubilant Pharma Limited
• 14.3. Tanner Pharma Group
• 14.4. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
• 14.5. Recipharm AB
• 14.6. Mission Pharmacal Company
• 14.7. Partner Therapeutics, Inc.
• 14.8. Novartis AG
• 14.9. Viatris Inc.
• 14.10.Coherus Biosciences Inc.

15. Strategic Recommendations

16. About Us & Disclaimer